RGLS
Regulus Therapeutics Inc
Halal Rating :
Last Price
$1.24
Last updated:
Market Cap
-
7D Change
-4.62%
1 Year Change
6.44%
Company Overview
Industries
Exchange
Next Earnings Date
Regulus Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. The company's lead product candidate, RGLS8429, is being developed for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The company is currently in clinical stage development and does not yet generate revenue from product sales.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Regulus Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.